News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$SLXP DD Notes ~ http://www.ddnotesmaker.com/SLXP
bullish
quick trade
$SLXP recent news/filings
## source: finance.yahoo.com
Wed, 24 Dec 2014 23:02:30 GMT ~ Nasdaq stocks posting largest percentage decreases
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220242625--finance.html
*********************************************************
Wed, 24 Dec 2014 22:04:00 GMT ~ DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Salix Pharmaceuticals, Ltd. Of Upcoming Deadline
[Business Wire] - Rigrodsky & Long, P.A.:
read full: http://finance.yahoo.com/news/deadline-alert-rigrodsky-long-p-220400625.html
*********************************************************
Thu, 18 Dec 2014 21:35:17 GMT ~ Salix Said to Get Sale Pressure as Reuters Reports Paulson Stake
read full: http://www.bloomberg.com/news/2014-12-18/salix-said-to-get-sale-pressure-as-reuters-reports-paulson-stake.html?cmpid=yhoo
*********************************************************
Thu, 18 Dec 2014 19:42:41 GMT ~ Credit Suisse Raises Salix Pharmaceuticals Price Target
read full: http://finance.yahoo.com/news/credit-suisse-raises-salix-pharmaceuticals-194241894.html
*********************************************************
Wed, 17 Dec 2014 13:30:00 GMT ~ Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of January 6, 2015 Lead Plaintiff Deadline in Class Litigation - SLXP
[Business Wire] - The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds Salix Pharmaceuticals, Inc. investors of the January 6, 2015 deadline to move for appo
read full: http://finance.yahoo.com/news/lieff-cabraser-reminds-salix-pharmaceuticals-133000545.html
*********************************************************
$SLXP charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$SLXP company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/SLXP/company-info
Ticker: $SLXP
OTC Market Place: Not Available
CIK code: 0001009356
Company name: Salix Pharmaceuticals, Ltd.
Company website: http://www.salixltd.com
Incorporated In: DE, USA
$SLXP share structure
## source: otcmarkets.com
Market Value: $7,323,079,567 a/o Dec 24, 2014
Shares Outstanding: 63,723,282 a/o Nov 05, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$SLXP extra dd links
Company name: Salix Pharmaceuticals, Ltd.
Company website: http://www.salixltd.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=SLXP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=SLXP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=SLXP+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/SLXP/news - http://finance.yahoo.com/q/h?s=SLXP+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/SLXP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/SLXP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=SLXP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/SLXP
DTCC (dtcc.com): http://search2.dtcc.com/?q=Salix+Pharmaceuticals%2C+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Salix+Pharmaceuticals%2C+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Salix+Pharmaceuticals%2C+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.salixltd.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.salixltd.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.salixltd.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/SLXP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001009356&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/SLXP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/SLXP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=SLXP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=SLXP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/SLXP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=SLXP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=SLXP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=SLXP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=SLXP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=SLXP+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/SLXP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=SLXP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/SLXP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=SLXP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/SLXP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/SLXP/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/SLXP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/SLXP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/SLXP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=SLXP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=SLXP
$SLXP DD Notes ~ http://www.ddnotesmaker.com/SLXP
|
Followers
|
6
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
179
|
|
Created
|
09/05/07
|
Type
|
Free
|
| Moderators | |||
http://www.salix.com/
http://finance.yahoo.com/q/ks?s=SLXP
Salix Pharmaceuticals, Ltd. engages in acquiring, developing, and commercializing prescription drugs used in the treatment of various gastrointestinal diseases in the United States. Its products include Colazal capsules for the treatment of ulcerative colitis; Xifaxan tablet, which is a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers' diarrhea caused by noninvasive strains of E coli; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy; MoviPrep, a liquid polyethylene glycol bowel cleansing product; and Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. The company also offers Anusol-HC and Proctocort, the hydrocortisone creams and suppositories, which are indicated for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and various inflammatory conditions; and Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases. Salix Pharmaceuticals' products that are under development phase include Granulated Mesalamine that is used as a maintenance treatment for ulcerative colitis using a dosing regimen; Balsalazide Disodium tablets for treatment of acute and active ulcerative colitis; and Sanvar to treat acute esophageal variceal bleeding. The company has collaboration and product acquisition agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; ALW Partnership; Biorex Laboratories Limited; Cedars-Sinai Medical Center; the Debiopharm Group; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Menarini Pharmaceutical Industries S.R.L; Merck & Co., Inc.; Norgine B.V.; and Shire Pharmaceuticals Group plc. Salix Pharmaceuticals was founded in 1989 and is headquartered in Morrisville, North Carolina.
